| Neuromuscular Diseases |
NCT00979082: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer |
|
|
| Active, not recruiting | 3 | 186 | US | carboplatin, glutathione, paclitaxel, placebo | North Central Cancer Treatment Group, National Cancer Institute (NCI) | Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer | 10/14 | | | |
NCT00652990: Sirolimus to Treat Plexiform Neurofibromas in Patients With Neurofibromatosis Type I |
|
|
| Active, not recruiting | 2 | 18 | US | Sirolimus | University of Alabama at Birmingham, National Cancer Institute (NCI) | Neurofibromatosis Type 1, Plexiform Neurofibromas, Paraspinal Plexiform Neurofibromas | 08/14 | 08/14 | | |
3-Hole, NCT02317224: The Safety and Efficacy of "" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor |
|
|
| Recruiting | 2 | 240 | RoW | "3-Hole" subxiphorid and subcostal approach, 3-Hole approach, Trans sternal approach, median sternotomy, VATS approach, Video-assisted thoracoscope | Tang-Du Hospital | Thymectomy, Myasthenia Gravis | 12/24 | 12/24 | | |
NCT02326831: Congenital Muscular Dystrophy Study Analyzing Pharmacokinetics at Three Dose Levels in Children and Adolescents With Assessment of Safety and Tolerability of Omigapil |
|
|
| Recruiting | 1 | 30 | US | Omigapil | National Institute of Neurological Disorders and Stroke (NINDS) | Dystrophy | 07/17 | 07/17 | | |
NCT01373333: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome |
|
|
| No Longer Available | N/A | | US | 3,4 DAP | The Cleveland Clinic | Lambert-Eaton Myasthenic Syndrome | 09/12 | | | |
NCT01378546: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP |
|
|
| No Longer Available | N/A | | US | 3,4-diaminopyridine | Louis H. Weimer, MD | Lambert Eaton Myasthenic Syndrome (LEMS) | 05/15 | | | |
NCT02176798: Variability of Molecular Biomarkers and Clinical Measures in People With Myotonic Dystrophy Type 1 |
|
|
| Recruiting | N/A | 24 | US | | National Institute of Neurological Disorders and Stroke (NINDS), University of Rochester, New York | Muscle Myopathies, Muscular Dystrophy, Inherited Neuromuscular Conditions | 01/16 | 01/16 | | |
NCT02166385: Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel |
|
|
| Active, not recruiting | N/A | 46 | US | pregabalin, 3-Isobutyl GABA, CI-1008, Lyrica, PD-144723, placebo, PLCB, questionnaire administration | Mayo Clinic, National Cancer Institute (NCI) | Pain, Peripheral Neuropathy | 12/16 | | | |
NCT00138931: Genetics of Cardiovascular and Neuromuscular Disease |
|
|
| Recruiting | N/A | 2000 | US | Blood draw (genetic testing) | University of Chicago | Cardiomyopathy, Arrhythmia, Muscular Dystrophy | 01/26 | 01/26 | | |
NCT02280733: A Real World, Observational Registry of Chronic Wounds and Ulcers |
|
|
| Recruiting | N/A | 175000 | US | Usual care, usual and customary care | U.S. Wound Registry | Diabetic Foot, Varicose Ulcer, Pressure Ulcer, Surgical Wound Dehiscence, Vasculitis, Skin Ulcer, Leg Ulcer, Wounds and Injuries, Pyoderma, Peripheral Arterial Disease, Diabetic Neuropathies, Lymphedema, Venous Insufficiency, Diabetes Complications, Amputation Stump | 01/25 | 01/26 | | |